Clinical Trial Update: A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for JNJ-95475939 in adults with moderate to severe atopic dermatitis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• JNJ-95475939

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Dermatitis, Atopic | Phase 2 | Status: ACTIVE_NOT_RECRUITING